In humans, a sizable burden of inherited mutation contributes to ill health throughout the world 1 . The bulk of this morbidity and mortality derives from transmission of mutations from affected or carrier parents to their children. Some affected individuals also arise each generation as a result of inheriting a de novo autosomal dominant or X-linked germline mutation. Although new mutations are rare, they are the source of the heritable genetic variation that contributes both to adaptive evolution and to our species' genetic burden.
, and 'genomic disorders' [8] [9] [10] [11] [12] [13] caused by copy number variation. Remodelling of chromosomes by retrotransposition [14] [15] [16] , translocation 17, 18 or inversions 8, 17 is also observed. In this Review we concentrate mostly on nucleotide substitution mutations and the factors that influence their frequency and other characteristics (nucleotide changes that arise by gene conversion-like events are reviewed elsewhere 19 ). Space restrictions preclude discussion of the important contributions made by studies in model organisms.
In the past, mutation frequency estimates (BOX 1) were calculated by directly measuring the fraction of individuals born with a new disease mutation or by using data on disease prevalence in the population together with estimates of the reproductive fitness of affected individuals 20, 21 . It is now possible to make experimental estimates of human disease mutation frequencies at specific nucleotides through direct DNA analysis of male germline cells from normal individuals. Some of these studies have concluded that some new human mutations provide the premeiotic germ cell with a selective advantage over nonmutant cells. Features of human germline mutation can also be inferred using computational methods to analyse large DNA sequence data sets. In this Review we integrate new results from experimental and computational methods into the broader context of what we know about human germline mutation from work in human medical genetics, molecular biology and population genetics.
We initially describe direct and indirect methods to assess mutation frequency. Then we consider several disease mutations that arise more frequently than would be expected by chance, and examine whether these elevated frequencies result from an increased likelihood of substitution at these sites. In addition to elevated frequencies at individual nucleotides, other forms of mutation rate variation have been observed; we explore whether genomic factors can explain this variation. Finally, we consider the impact of parental origin and age. Together, these new findings provide a broader understanding of germline mutation dynamics and suggest how the direction of future data collection could help us to better define the factors that influence mutation frequency.
Ligase chain reaction
Amplification of a small DNA fragment by successive rounds of DNA ligation using one pair of adjacent primers for each of the two complementary target DNA strands.
Effective population size
The number of breeding individuals in an idealized population that would show similar characteristics to the population under consideration. For a number of reasons, the effective population size is typically smaller than the actual number of individuals in the population.
Achondroplasia
A common form of dwarfism, inherited in an autosomal dominant fashion.
Apert syndrome
An autosomal dominant disorder characterized by premature closing of cranial sutures and fused fingers and toes.
Spermatogonia
Premeiotic diploid cells of the mature male germ line.
Measuring substitution frequencies
In order to understand the implications of nucleotide substitution mutations for human disease and genetic variation it is essential to measure the frequency of substitutions at different sites in the genome. The principles of two current approaches -direct measurements using germline DNA and indirect measurements by comparative genomics -are described below.
Direct measurements using human germline DNA. obtaining quantitative estimates of new mutation frequencies using germline DNA requires availability of germline cells in numbers that exceed the reciprocal of the mutation frequency. Human semen is an ideal source of genetic material as a single sample can contain over 10 8 sperm. obtaining comparable numbers of mature female gametes from any mammal is not feasible.
one way to make direct estimates of nucleotide substitution frequencies using germline cells from normal individuals is to use PCR-based methods that are designed to only amplify molecules containing the substitution mutation under study 22, 23 . Alternatively, restriction enzymes may be found that destroy a significant proportion of the wild type (but not mutant) genomic template. PCR across the chosen nucleotide site follows the restriction digest and, subsequently, the product is subjected to DNA purification and sequencing 24 or to a ligase chain reaction 25 . In both cases, the mutation frequency at the site can be directly quantified. In a third approach 26,27 a dilution is found at which no more than a single mutant molecule (on average) is expected in any DNA sample. The number of samples containing a mutation is counted using a highly sensitive modification of PCR 28 . The frequency is estimated from knowing the total number of genome equivalents tested and the dilution factor. The first of these three approaches has the highest false positive rate and the last has the lowest. The second method depends on the mutation of interest eliminating an already existing restriction enzyme site and has an intermediate false positive rate.
Indirect measurements of mutation frequencies. The mutation frequency can be inferred indirectly by comparing aligned DNA sequences in different species. In addition to sequence data, this method requires estimates for the species divergence time, the generation times and the effective population size of the common ancestral species
. using human and chimpanzee data, Nachman and Crowell 29 estimated the average neutral mutation rate in the human genome to be 2.3 × 10 -8 mutations per nucleotide site per generation. later data sets have given similar sequence divergence rates [30] [31] [32] , and therefore suggest similar mutation frequency estimates.
In addition to the divergence between species, the diversity within a single species is also related to the mutation rate per generation
. As the diversity formula is more strongly dependent on population genetics assumptions (which are probably not true in natural populations) than the divergence formula, diversity is not often used to directly estimate mutation frequencies. However, both diversity and divergence are used to measure changes in mutation frequency with chromosomal position
.
Mutation hot spots?
Substitution mutations that cause human disease are of great interest, as understanding the dynamics of these mutations helps us to understand the origin of many genetic disorders. In this section we discuss how direct experimental evidence has recently provided further insights into why some disease-causing mutations are seen more often than expected.
Apert syndrome and achondroplasia. Analyses of DNA sequence information 29, 33 estimate the average substitution frequency per nucleotide site as between 10 -7 and 10 -9 . However, epidemiological analysis using hospital birth data on sporadic cases for two genetic conditions (achondroplasia and Apert syndrome) revealed high gene mutation frequencies: 10 -4 to 10 -5 for achondroplasia 34, 35 and 10 -5 to 10 -6 for Apert syndrome 36, 37 . Surprisingly, analysis of blood DNA showed that virtually all individuals with achondroplasia have a substitution at the same nucleotide site in the fibroblast growth factor receptor 3 gene (FGFR3) [38] [39] [40] ; and with Apert syndrome virtually all mutations arise at one of two nucleotides in FGFR2 (ReFs 41, 42) . Therefore, the Apert syndrome and achondroplasia birth data suggest a nucleotide substitution frequency that is higher by a factor of 100-1,000 than the average estimates 29, 33 . The standard explanation for this discrepancy is that these particular nucleotides have a much higher than average chance of undergoing a base substitution -they are mutation hot spots.
Testing the mutation hot spot model. Recently, new experimental approaches have been devised to test whether any particular nucleotide site is a mutation hot spot in the germ line. one method 26, 27 argues that most base substitutions take place in the A-pale class of spermatogonia (Ap), which are self-renewing (Sr) and divide continuously throughout a man's life. These SrAp cells are uniformly scattered along the basal membrane of the
Box 1 | Mutation frequency
The term 'mutation frequency' refers to the proportion of all gametes containing a new (spontaneous or de novo) mutation. This proportion should be approximately equivalent to, for example, the proportion of children born to unaffected parents (sporadic cases) for a trait inherited in an autosomal dominant fashion. At one extreme, the term could refer to the sum of all mutations of any type in a particular gene that lead to the same recognizable phenotype (the gene mutation frequency); at the other extreme it can refer just to the frequency of a particular type of mutation at a specific nucleotide site. In either case 'mutation frequency' is commonly used interchangeably with 'mutation rate per generation'. The latter is often shortened to 'mutation rate' (as in this Review), but it should be distinguished from the 'mutation rate per cell generation' (also often shortened to 'mutation rate') that can be measured in experiments on single-cell organisms. In multicellular organisms both the number of germline cell generations and the time in development when the mutation arose cannot be precisely established (early mutations can inflate estimates of the number of independent mutation events), so estimated mutation rates per cell division are likely to be imprecise.
Transversion mutation
A point mutation in which a purine base is substituted for a pyrimidine base and vice versa; for example, an A•T to C•G transversion.
Multiple endocrine neoplasia type 2B
Mutation in the proto-oncogene RET. The mutation is inherited in an autosomal dominant fashion and leads to early childhood thyroid cancer.
seminiferous tubules, which are themselves uniformly distributed throughout the testis (FIG. 1) . It follows that if a nucleotide site is highly prone to mutation (it is a hot spot) and the mutation frequency is high enough, mutant SrAp cells (and their meiotic and postmeiotic descendents) will be found uniformly distributed throughout the testis (FIG. 2a) .
To study the two cytosine to guanine transversion mutations in FGFR2 that cause Apert syndrome (755C>G and 758C>G), testes from older normal men were dissected into ~200 pieces while retaining information on their three-dimensional relationships to one another. A modified PCR assay 28 was used to estimate the mutation frequency in each piece. In each of four older donors (aged 44-62 years) the mutant cells were not uniformly distributed in the testis (FIG. 2b) . Instead, a few pieces (often adjacent ones) contained most of the mutant cells; some pieces had frequencies 10 3 to 10 4 times greater than the remaining ones 26, 27 . on average, 95% of the mutations were found in just 5% of the testis pieces -further illustrating the observed clustering. To determine whether these clusters result from mutations early in testis development a mathematical model for germline mutation was proposed 26, 27 . According to this model, the clustering observed in the testis is unlikely to be due to these early 'jackpot'-producing mutations; therefore, the hot spot model was rejected. Further data supported the conclusion that the mutation clusters were not initiated early in testis development. For two younger donors (aged 19 and 23 years) there were either no clusters or the clusters had much lower frequencies 26 ; also, a presumably neutral C>G mutation on another chromosome was spread uniformly throughout both testes of an older donor 27 . An alternative approach to test the hot spot model, using only sperm, was developed for the Apert syndrome 755C>G mutation 24 . This approach requires a highly informative SNP extremely close to this site (so that both can be amplified on the same DNA fragment). For each individual heterozygous for the SNP, the frequency of the 755C>G mutation is measured. The same is done for the non-Apert syndrome 755C>T mutation. The researchers assumed that, if both substitutions are neutral in the testis, then the mutation with the higher observed frequency is the result of more mutation events. For each individual, and for each mutation separately, the authors also examined how the mutant molecules were partitioned between the two SNP allele types (A or a). each mutation is expected to have arisen with equal probability on a chromosome with SNP allele A and a chromosome with SNP allele a. Therefore, the fraction of mutant molecules with SNP allele A, for example, should be closer to 50% for the higher frequency substitution than for the lower frequency substitution. The opposite of this expectation was reported, and it was concluded that the higher 755C>G substitution frequency was not caused by more mutation events -thereby rejecting the hot spot model 24 . Whether these particular data are inconsistent with the hot spot model has been questioned 27 . However, other features of Apert syndrome have also led to the validity of the hot spot model being questioned 23, [43] [44] [45] .
Selection can alter the frequency of germline mutation. An early explanation for the unexpectedly high frequency of individuals born with Apert syndrome or with achondroplasia suggested that premeiotic testis cells carrying the causal mutations had a selective advantage 23, 45 . The same hypothesis can explain the Apert syndrome testis dissection data 26, 27 (FIG. 2c) and the sperm analysis data 24 . more specifically, to explain the mutation clusters observed for both 755C>G and 785C>G in the testis dissection data 27 , the authors proposed that SrAp cells that harbour either of the two mutations had a selective advantage over wild-type SrAp. This advantage was suggested to occur because mutant SrAp cells may occasionally divide symmetrically (FIG. 3) to produce two SrAp cells, instead of only replacing themselves as wild-type SrAp cells do 26, 27, 44 . Thus, even if only 1% of mutant SrAp divisions are symmetric, the observed high mutation frequency and mutation clusters can be explained even when the nucleotide substitution rate per cell division is similar to the genome average rate inferred for neutral C to G transversions 29, 33 . The molecular mechanism that might be responsible for such a selective advantage is unknown. However, information on the molecular pathways involved in asymmetric and symmetric cell divisions in model organisms could be especially pertinent 46, 47 .
Positive germ line selection may explain mutations in other genes. In addition to Apert syndrome, other disease mutations may also be subject to positive selection in the germ line. In TABLe 1 we compare the features of Apert syndrome with three other diseases, and find that the similarities suggest positive selection. For achondroplasia, although complete testis dissection accompanied by quantitative analysis is lacking, analysis of two biopsies from each of four testes 48 revealed that for old individuals the two biopsies from the same testis had different mutation frequencies, whereas for the testes from middle-aged donors the two biopsies from the same testis had similar mutation frequencies.
Box 2 | Divergence and diversity
The divergence between two species is computed by counting the sequence differences between a representative of each species. The divergence can be computed for chromosomal blocks of various sequence lengths, and at different positions. For neutrally evolving sequences, the average divergence is 2ut + 4N α u, in which u is the mutation rate per generation, t is the divergence time measured in generations, and N α is the effective population size of the ancestral population common to the two species (for an example, see ReF. 29) . The mutation rate can be adjusted for the block sequence length to calculate an average per nucleotide site value. The 2ut term derives from the two branches in the separate species, and the 4N α u term comes from the coalescence time (the time to find a common ancestor) in the ancestral species. Obviously, there is considerable uncertainty in the 4N α u term, and the two species are selected such that the 2ut term is much larger. Moreover, as the coalescence time varies for different regions of the genome (owing to recombination) some variation in divergence with chromosomal position is expected; however, the observed variation in divergence is greater than that expected from the variation in coalescence time 30 . Diversity is a measure of genetic variability within a population. The average diversity is 4N e u, in which N e is the effective population size.
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Figure 1 | Human testis and epididymis. A whole testis with epididymis attached is shown in the inset box. A cross-section through the epididymis and partial exposure of the interior of the testis shows the seminiferous tubules. The testis is oriented with respect to the head and tail of the epididymis. The lumen of each tubule provides a pathway for sperm to reach the epididymis and the vas deferens.
Transition mutation
A point mutation in which a purine base (adenine or guanine) is substituted for a different purine base, and a pyrimidine base (cytosine or thymidine) is substituted for a different pyrimidine base; for example, an A•T to G•C transition.
Rett syndrome
An X-linked neurodevelopmental disorder that is associated with mental retardation. It is found sporadically and almost exclusively in females who inherit a new mutation in the methyl-CpG-binding protein 2 gene (MECP2) from their father.
As with Apert syndrome, mutations leading to achondroplasia and multiple endocrine neoplasia type 2B (meN2B) occur in receptor tyrosine kinases that are implicated in cancer and have a proliferative role during normal development [49] [50] [51] . meN2B mutation data seem to share the characteristics of Apert syndrome mutation data, except that the available data make it difficult to calculate whether the frequency of sporadic cases significantly exceeds that expected for a thymidine to cytosine transition mutation [52] [53] [54] [55] . Interestingly, data suggest that the receptor tyrosine kinase ReT, which is mutated in meN2B, is required for spermatogonial self-renewal in mice (reviewed in ReF. 56) .
The last and most speculative possibility listed in TABLe 1 is Rett syndrome [57] [58] [59] [60] . eight different recurrent and usually inactivating nucleotide substitutions at CpG sites account for 61% of all mutations. The gene that is mutated in Rett syndrome encodes methyl CpG binding protein 2 (meCP2), which specifically binds m 5 CpG sequences (CpG dinucleotides with the cytosine methylated at the 5-position). Alteration or inactivation of meCP2 could have wide ranging and possibly advantageous effects on spermatogonia that lack the m 5 CpGbinding activity, as meCP2 acts as a transcriptional repressor. However, a striking paternal age effect (PAe; discussed below) in Rett syndrome seems to be absent.
undoubtedly, genes that are responsible for other autosomal dominant or X-linked genetic conditions and that match several of the criteria shown in TABLe 1 may also be candidates for providing mutant male germline cells with a selective advantage.
Germline selection may not be restricted to nucleotide substitutions. Well-documented examples of selection exist for trinucleotide-repeat expansion mutations [61] [62] [63] [64] [65] [66] [67] [68] . In fragile X syndrome, for example, affected adult males with a disease allele in their cells do not produce sperm that carry the disease allele; instead, the sperm carry significantly contracted alleles. examination of the gonads of affected fetuses of different ages suggested that germ cells carrying smaller alleles increase in frequency as testis development proceeds, possibly because they have an advantage over cells with a disease allele.
Also, germ line selection may not be limited to males. one recent study proposes that selection during the fetal and postnatal life of ovarian germline cells carrying trisomy 21 may contribute to the well-known Down syndrome maternal age effect 69 . Finally, new gainof-function mutations with a selective advantage in the germ line are more likely to be transmitted to the next generation because the effective mutation frequency is elevated beyond what the underlying rate of mutation alone can achieve. When such mutations cause the fitness in the offspring to decrease, the genetic burden on the population is increased 70 .
Variation in substitution frequency
The direct method, discussed above, measures the mutation frequency at individual nucleotide sites and has found that, in the male germ line, some sites have frequencies much greater than the genome average. The indirect method infers average frequencies in sequence blocks much wider than a single nucleotide, and has found that these averages vary with the chromosomal position of the blocks. Indeed, sequence divergence varies significantly between blocks in the same chromosome 30, [71] [72] [73] , between different autosomes 30, 31, 73 , and between autosomes and sex chromosomes 30, 31, 73 . This last observation will be discussed further in the next section. Possible explanations for this high level of variation include local heterogeneity in the mutation rate or in DNA repair efficiency, and selection on specific mutations (positive or negative). Here we discuss selection on the organism's phenotype, whereas in the previous sections we discussed selection only in the germ line. The possibility of selection, and the recent explosion of genome data, has spawned many papers attempting to find genomic factors that vary with divergence and diversity, which we will discuss next.
Coding and non-coding comparisons. It has long been appreciated that, owing to purifying selection, both diversity and divergence are greater in non-coding regions than in coding regions, and are greater at synonymous sites than at non-synonymous sites in coding regions. In order to estimate the neutral mutation rate, researchers have traditionally focused on non-coding regions, in one dissected human testis from a 62-year-old donor. The testis was divided into 6 slices, and each slice was divided into 32 pieces from which DNA was isolated. A separate aliquot was used to study the mutations. The orientation of the testis is relative to the head (on the left, slice 1) and tail (on the right, slice 6) of the epididymis, the long axis of which runs along the upper surface (slices 1-6). The distribution of high-frequency pieces is not overly represented on the perimeter of the slices 26, 27 . 
Transcription-coupled repair
A form of DNA repair that removes DNA lesions that inhibit the progression of RNA polymerase during transcription. The repair process specifically targets lesions on the template strand.
Biased gene conversion
A non-reciprocal copy and paste of one allele onto the other one at heterozygous loci during meiotic recombination. some authors have proposed that this process is biased such that at a site heterozygous for a G•C or C•G allele and an A•T or T•A allele there will be more G•C or C• G gametes produced.
Recombination fraction
estimate of the proportion of all gametes that were derived from meiotic crossing-over events in a chosen interval.
synonymous sites or ancestral repeats 73 . However, it is difficult to know which regions of the genome are truly neutral (see ReF. 73 for an example), as numerous noncoding regions were found to be conserved, presumably because of selection, and there is evidence that synonymous sites are subject to selection. A more subtle difference involving mutation frequency and coding regions has also been observed: there is an asymmetry favouring guanine and thymidine nucleotides over adenine and cytosine nucleotides on the coding strand of genes in mammals 74, 75 , which is possibly due to the bias introduced by transcription-coupled repair 76 . A later, larger study generally confirmed this bias, but found bias in the opposite direction in the first 1-2 kb downstream of the 5′ end of genes 77 -an observation that requires a distinct explanation. The transcription-coupled repair hypothesis predicts a stronger bias in genes that are highly expressed in the germ line; this was tested for a set of ubiquitously expressed housekeeping genes and it was found that the average expression level across a broad range of tissue types was correlated with the strength of the mutational bias 78, 79 . We are not aware of a study that tests this prediction with expression values measured directly in germline cells, but this would be a worthwhile study.
Base identities. It has also long been appreciated that transitions are more likely than transversions, and that CpGs have higher mutation rates than other sequence contexts
. Relative to their expected frequency in the genome, a large proportion of new mutation events responsible for genome-wide nucleotide polymorphisms and human disease occur at 5′-CpG-3′ sequences 29, [80] [81] [82] (discussed further in the next section). Researchers have considered other local contexts and have found effects on mutation rates, although they are not as strong as the effect of CpG context [83] [84] [85] [86] . A recent paper has further suggested that non-local contexts may also play a part 87 . moreover, while not introducing new mutations, biased gene conversion 88, 89 is believed to complicate the analysis discussed in BOX 2 by favouring the transmission of guanine or cytosine alleles at the expense of adenine or thymidine alleles at already polymorphic sites, producing an effect somewhat similar to a biased form of recurrent mutation.
Other factors. Divergence and diversity have also been found to vary with GC content 30, 71, 72, 90 , CpG density (even for non-CpG mutations 91 ), proximity to the ends of chromosomes 30, 72 , broad meiotic recombination fractions inferred from pedigrees 72, 90, 92 , fine-scale recombination hot spots inferred from population genetic data 93, 94 , and the intensity of Giemsa staining in cytogenetically defined chromosome bands 30 . Interestingly, both diversity and divergence are positively correlated with broad recombination fractions, but only diversity is correlated with finescale hot spots, presumably because these recombination hot spots are short-lived relative to human-chimpanzee divergence times (reviewed in ReF. 95) .
of course, many of these genomic factors are confounded with each other. The Chimpanzee Consortium 30 observed that: "multiple mechanisms are at work, and that no single factor, such as GC content or recombination rate, is an adequate predictor of regional variation in the mammalian genome by itself. " likewise, in an earlier review 73 , ellegren stated that: "[it is] highly unlikely that there is a single factor that can explain mutation rate variation." Some researchers have attempted to fit models using many of these factors as dependent variables 72, 90, 96 . The mutation hot spot (a) and selection (b) models of germline cell division are shown schematically. In each case there is a growth phase and an adult phase. Two independent mutation events (red ×) are shown in the hot spot model (a). The mutation in the adult phase produces one mutated self-renewing spermatogonial (SrAp) cell lineage (red line), whereas the mutation event in the growth phase produces four mutated SrAp cell lineages. In the selection model (b) one mutation event in the adult phase produces three mutated SrAp cell lineages (from two symmetric rather than asymmetric cell divisions) that would form a cluster within the testis. Figure is reproduced from ReF. 27 .
Epigenomics
Analysis of epigenetic marks (DNA and protein modifications) on a genome-wide scale.
Duchenne muscular dystrophy
A disorder caused by mutations in the X-linked dystrophin gene and characterized by rapidly worsening muscle weakness.
Haemophilia A
A blood clotting disease resulting from mutations in the X-linked factor VIII gene.
A further factor that was not included in the above models, and which has since been shown to be correlated with divergence, is the proximity to small (<101 bp) insertions or deletions 97 (known as indels). It has been proposed that heterozygosity for an indel, or indel creation itself, could be mutagenic to the surrounding sequences. Although there is no evidence that indelassociated mutation depends on meiotic recombination rate, DNA double-stranded break formation in premeiotic germ cells is still a possible cause of these mutations because repair of DNA double-stranded breaks by nonhomologous end joining is potentially error prone 98 , as is repair by homologous recombination 99 . In addition to genomic sequence data, epigenomic data is also being collected. one publication 100 observed that, as measured by indirect means, the rate of mutation tends to be lower in the open chromatin regions of the genome than the closed regions. The authors argued that this difference was due to greater accessibility of repair mechanisms in the open regions. However, one caveat to applying this work to germline mutation is that the open and closed chromatin structure was determined in transformed lymphoblastoid cell lines, and these structures may be different in germline cells.
Sex differences in mutation
In this section we first discuss how paternal or maternal mutation bias is assessed (using direct and indirect methods), and then we examine a number of possible explanations for this bias (that is, the influence of the type of mutation, DNA methylation and DNA repair). The first hint that there is a male mutation bias came from studies on mutation frequency using disease prevalence data and population genetics reasoning regarding the effect of the disease on fitness 101 . Since then, many additional cases have been found in which more de novo disease mutations come either from the father or mother, depending on the type of mutation event (reviewed in ReFs 20, 44, [102] [103] [104] [105] .
Direct analysis of patients. Discovering the parent of origin of a mutation using SNP data does not require knowledge of the type of mutation, but it is difficult to interpret. Data on the tendencies for different types of mutation events in the two sexes can provide a better understanding of the factors underlying mutation bias. In many genes the vast majority of new disease mutations are nucleotide substitutions (as in achondroplasia and Apert syndrome), whereas different events (such as deletions and duplications) contribute to other diseases. In achondroplasia and Apert syndrome, the causal base substitutions are almost always of paternal origin 21, 44 . However, in X-linked Duchenne muscular dystrophy (DmD), deletion events show a female bias whereas base substitutions exhibit a male bias 106 . In haemophilia A (also X-linked), the majority of mutations are either missense or nonsense substitutions (48%), or large meiotic inversions involving intron 22 (36%). Both the base substitutions 107 and inversion events 108 in haemophilia A show a male bias (arising in the maternal grandfather, as fathers do not transmit X chromosomes to their sons), whereas deletions, as in DmD, are female biased 107 . Data on other disorders are also available 20, 44, [102] [103] [104] [105] 109, 110 . The situation is clearly highly variable among diseases, which probably reflects the tendencies of the male and female germ lines to undergo different kinds of mutation events.
In general, the most accurate calculation of male or female spontaneous mutation biases requires the ability to detect a wide variety of mutation types and a large sample of mutations. The absence of ascertainment bias in selecting affected individuals for study is also important because mutations causing severe disease are more likely to be noticed than those causing mild disease. Also, what seems to be a new germline mutation originating in an unaffected parent might actually result from a post-zygotic mutation early in the development of the affected individual, leading to mosaicism [111] [112] [113] [114] [115] [116] [117] [118] . Such cases are important to ascertain as mutations in the embryo may not arise under the same constraints as in the male or female germ lines. Finally, studies in mice and fish [119] [120] [121] raise the possibility that some mosaicism may result from delayed or transgenerational mutations, in which a premutagenic lesion originates in the germ line of the unaffected parent but is not fixed as a mutation until after fertilization.
Indirect analysis of bias. Sex-based nucleotide substitution mutation bias, but with a genome-wide perspective, can also be inferred from DNA sequence divergence between species 104, 105, 122, 123 . After adjusting for the fact that over evolutionary time an autosome is equally likely to reside in a male or female germline cell whereas an X chromosome experiences a female cell environment 66% of the time (33% in a male cell environment), a strong male bias (α) for neutral nucleotide substitutions is detected. For example, the sequence divergence between
CpG island
A region at least several hundred base pairs in length that is characterized by a high GC content and a large number of unmethylated CpG dinucleotides. CpG islands are found to overlap a large fraction of human gene promoters.
Bisulphite sequencing
Chemical treatment of genomic DNA before sequencing that allows identification of those cytosines that were methylated in the DNA from a particular tissue source. Unmethylated cytosines are converted to uracils, whereas methylated cytosines remain unmodified.
the X chromosomes of humans and chimpanzees can be compared with estimates of the autosomal divergence (that is, the normalized ratio of X to autosomal mutations), for which α ≈ 3-8 (reviewed in ReF. 124) .
The above male-driven evolution model is usually explained by noting that SrAp cell divisions occur throughout a man's life, whereas oogonia cease replication during fetal life after ~30 cell generations 125 . Thus, sperm from 20-year-old men (the approximate time between generations during human-chimpanzee evolution 29 ) come from SrAp cells with a history of ~195 cell generations. When compared with the cell generation history of a female gamete this amounts to an approximately sixfold male bias, and is remarkably consistent with the α values that are based on the DNA divergence studies. In general, such considerations have been taken as evidence that cell replication-dependent events are more important than replication-independent processes in dictating nucleotide substitution frequencies, but this is not true for all mutation types even when only base substitutions are considered (see below).
Do different kinds of nucleotide substitutions show the same male bias?
The recent estimate of α (ReF. 124) was based on the human-chimpanzee sequence comparisons. The study also contrasted mutations at CpG sites, where the cytosines are often methylated, to those at CpG sites in CpG islands, where they are rarely methylated. The results were striking: CpG sites in CpG islands show the strong male bias that is typical of non-CpG sites (α ≈ 7-8), but CpG sites elsewhere in the genome show a highly significant reduction in bias (α ≈ 2). The authors conclude, as have others based on less extensive data sets (reviewed in ReF. 124) , that G•C to A•T transitions at CpG sites may be less dependent on an excess of male germline cell generations than other nucleotide substitution types because a spontaneous chemical event (deamination) initiates the mutation, rather than some other event that is specifically associated with DNA replication. This recent work is important because it points out the advantage of accumulating mutation information from sequence data that are parsed according to the exact nature and context of the molecular event, and also because it influences how we interpret the role of age in new mutation formation (discussed below).
Alternative explanations for the low male bias of CpG mutations. There is a hidden assumption in the argument that the low male sex bias for CpG mutations existing outside of CpG islands results from the fact that the mutation event is a spontaneous chemical reaction. This assumption is that the rate-limiting step for a transition mutation at an m 5 CpG site is the spontaneous deamination event
. mechanistically, the situation may be more complex. The chance that a sperm or egg contains a CpG to TpG transition at a particular site actually depends on whether the cytosine was methylated, the relative deamination rates of m 5 C compared with cytosine (m 5 C > cytosine 126 ), and the likelihood that the pre-mutagenic lesion (a G•T mismatch for m 5 C or a G•U mismatch for cytosine) is restored to a G•C by DNA repair before the next replication event. We know little about these three processes in human germline tissues. Below we discuss what we do know about these factors in humans and speculate (BOX 4) on how they might interact with one another to result in a low male bias at CpG sites.
Regarding the methylation status of CpG sites in males versus females, data from mice indicate the time course of methylation and demethylation in the male and female germ lines, but the focus has previously been on retrotransposons, X inactivation or imprinted genes (reviewed in ReFs 127, 128) rather than on the majority of single-copy coding sequences that would be major targets of disease-causing nucleotide substitutions. In humans, a large and more inclusive set of single-copy targets have recently been studied by bisulphite sequencing 129 . However, only sperm (rather than SrAp cells or female germline tissues) were examined. A small number of human CpG sites in the coding sequences of disease genes have been studied in the germ line 130 : analysis of a total of 33 CpG sites at the factor VIII and FGFR3 genes showed little difference in CpG methylation levels in mature oocytes relative to mature sperm.
Cytosine deamination is usually assumed to be spontaneous; however, enzymatic deamination pathways are known to exist [131] [132] [133] . Data on possible roles of enzymatic deamination in male and female germline tissues are limited, but do suggest that levels of one cytosine deaminase is higher in oocytes than in spermatogonia 131, 132 . 
Box 3 | Mutation of methylated CpG dinucleotides
Cytosine is chemically less stable than the other three bases and can spontaneously undergo a deamination reaction that converts it to uracil, forming a G•U mismatch. This premutagenic lesion must be repaired so that a daughter strand is not converted to an A•U base pair during the next round of DNA replication, thereby fixing the G•C to A•T mutation. DNA base excision repair may remove the uracil at the G•U mismatch using the enzyme UNG (uracil DNA glycosylase), and subsequently replace it with cytosine (reviewed in ReF. 150) .
A common epigenetic modification to DNA that occurs almost exclusively at a palindromic 5′-CpG-3′ site (that is, a CpG dinucleotide) involves methylation of cytosine at the 5-position ( Knowledge of DNA repair capabilities in human germ lines -especially of G•T and G•U mismatches -is also scarce [134] [135] [136] , although data on efficiencies of some repair pathways are available for mouse germ cells 137, 138 . The timing of G•T and G•U pre-mutagenic lesion repair in males and females is also important. If it is not repaired quickly enough in male embryonic and fetal germ cells, or in adult male SrAp cells, then the mutation will be fixed following DNA replication. The same is true in the female germ line until mitotic divisions cease during fetal life. Thereafter, pre-mutagenic lesion repair could occur at any time throughout adulthood until the first round of DNA replication is initiated after the mature egg is fertilized. G•T mismatches may also be subject to other repair pathways 139 , and the expression levels of repair proteins in different pathways can be differentially regulated during the cell cycle 140, 141 , perhaps in a sex-specific way. The considerations described in this section suggest alternatives that might explain the low α value at CpG sites. BOX 4 shows, qualitatively, how the low male mutation bias at CpG sites outside of CpG islands 124 could be due to a sex difference in methylation, enzymatic deamination or repair. Clearly, combinations of such alterations could achieve the same theoretical result; more experimental data are needed to understand the basis for the low male bias at CpG sites.
Age effects on mutation frequencies maternal age effects for chromosomal aneuploidy (for example, Down syndrome) are well known 2, 3 . Based on the above discussion of sex differences in base substitution mutations and the high ratio of male to female germline cell generations it is not surprising that, for a number of genetic conditions, the chance of a sporadic case being born increases as the father ages -the PAe 20, 21, 44, 103, 142, 143 (see ReF. 144 for conflicting results). male-driven evolution would predict a linear paternal age-dependent increase (owing to the asymmetric divisions of SrAp cells). However, for a number of diseases the increase is exponential 143 . Direct studies on sperm mutation frequencies in male patients with Apert syndrome or achondroplasia [22] [23] [24] 48 reveal an increase with age, but these studies have had variable success in establishing that the increase is exponential as suggested by epidemiological studies 143 . This inconsistency was first explained by proposing that sperm mutation frequencies may increase linearly but that sperm (not premeiotic cells) carrying such mutations have a selective advantage in fertilization, leading to an overall exponential increase in sporadic cases 22, 23, 48 . However, the data on sperm mutation frequencies have been questioned in regards to the sensitivity of the mutation assays, sperm donor sample sizes and other factors 23, 145 . The authors of one sperm study on the Apert syndrome 755C>G mutation argued that their data are consistent with an exponential increase in births, but they did not test the hypothesis statistically 24 . A more recent study examining both Apert syndrome mutations (755C>G and 785C>G) in each sperm sample has provided statistical verification for an exponential increase using a larger sample size of sperm donors and a more sensitive Apert mutation assay (N.A., P.C., S.-R. yoon, R.l. Glaser, e.W. jabs, N.S. Wexler, R. Sokol and j. Qin, unpublished observations).
An exponential increase in mutagenic events or an exponential decrease in DNA repair capacity as the germ line ages could supplement the linear male-driven evolution that is directed by the number of generations in SrAp cells (α ≈ 3-8, reviewed in ReF. 124) and also provide a basis for an observed exponential increase 44 , but experimental evidence in humans is lacking for both these possibilities. more importantly, neither factor could explain the observed clustering of Apert syndrome mutations in testes 26, 27 (described above). However, selection on mutant SrAp cells 24, 26, 27, 44 can explain both the exponential increase observed in the epidemiological data and the mutation clustering in the testes of older donors. likewise, the selection model can explain the lower mutation frequencies and smaller clusters observed in the testes from younger donors 26, 27 . A number of diseases exhibit a more linear increase in sporadic cases with the father's age (for example, neurofibromatosis type 1 (ReFs 20, 44, 143) ). male-driven evolution alone, in the absence of selection, could theoretically account for such cases. However, the magnitude of the linear increase could depend on the nature of the mutations causing the disease. As discussed above, nucleotide substitution mutations at non-CpG sites (or at CpG sites in CpG islands) have an α value of ~7-8 -large enough to expect a linear PAe. In diseases for which most mutations arise at CpG sites outside of CpG islands, the expected α value of ~2 would make it difficult to detect a PAe 144, 146 other than in an exceptionally large epidemiological study. However, in achondroplasia, for which all new mutations arise at the same CpG site (shown to be methylated in mature sperm 130 ), the observed exponential PAe is probably due to selection acting on SrAp cells carrying the mutation. overall, most diseases arise from a mixture of different genetic events, some of which show a strong male bias and others a strong female bias (see above). Some, but not all, of these mutation events may show an age-dependent frequency increase. In such cases, detecting a paternal or maternal age effect would depend on the relative proportion of the different types of disease mutation.
Box 4 | Possible effects on male bias
The figure shows the effect on male bias (α) of factors (discussed in the main text) that could influence the mutation frequency of a cytosine in different contexts in males (M) versus females (F). For a cytosine at non-CpG sites, the difference in total cell divisions is assumed to be the most important factor in explaining the high α value; no sex difference in deamination or DNA repair is assumed. For a cytosine at a CpG site, all the listed factors are also assumed to be equal in both sexes except for the number of cell divisions (which is always greater in males). If, however, an inequality (shown in blue) did exist (for example, enzymatic deamination was greater in females than males) and was of sufficient magnitude, it might lead to a low α value. Repair is taken to mean base excision repair, DNA mismatch repair or both. A, a sex difference is assumed in methylation; B, a difference in enzymatic deamination is assumed; C, a difference in repair is assumed; m 
Summary and future prospects
In recent years new experimental approaches have made it possible to estimate the frequencies of new human germline mutations at specific nucleotide sites. Such studies have contributed evidence that some mutations may provide germline cells with a selective advantage, thereby increasing the observed mutation frequency beyond the actual number of mutation events that occur each generation. equally exciting is the possibility that other types of mutation event besides base changes may also contribute disproportionately to the human mutational load because of germline selection. Clearly, examination of the diseases listed as possible candidates in this Review, as well as other candidates, might provide new insights into the role that germline selection may have in affecting mutation frequencies. Recent computational approaches to studying germline mutations using the ever increasing amount of genomic data have also revealed new complexities regarding the factors that could influence mutation processes. These studies have the advantage of a genomewide perspective, and the large amounts of data have provided convincing evidence for their conclusions. The accumulation of more DNA sequence data as well as new analytic tools should help to further our understanding. It is important to emphasize that the experimental and computational approaches are complementary. The indirect approach could never have found the elevated frequencies at the Apert syndrome and achondroplasia disease sites, nor the paternal age effect. As mutation rates are low, the indirect method of comparing species or individuals within the same species has provided far more mutation data than is currently feasible with the direct method. However, as sequencing technology becomes less expensive, more direct studies may be possible by sequencing pedigrees.
A number of long-standing assumptions about the roles of different factors in human germline mutation have little direct experimental support, primarily because of the difficulty of studying human germline tissues. methods for culturing mouse germline stem cells under in vitro conditions are developing, and procedures for transplanting such cells into the mouse germ line or, in some cases, carrying out spermatogenesis in vitro have been described [147] [148] [149] . As such systems mature they could provide an ideal starting point for studying patterns of DNA methylation and DNA repair on homogeneous populations of relevant mouse and, eventually, human germline cells.
